Lymphoma
SOHO Brazil 2022
SOHO Brazil 2022: Are All MZLs the Same? What Do We Know About Subtypes & Transformation?
FEATURING
Izidore Lossos,
Phillip Scheinberg
- 33 views
- August 31, 2022
SOHO Brazil 2022
Are We Curing Some Mantle Cell Lymphomas?
FEATURING
Julio Chavez,
Alvaro Alencar
- 66 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on Bispecifics in Follicular Lymphoma: A “Mini-Revolution”
FEATURING
Julio Chavez,
Alvaro Alencar
- 20 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on CPIs in Hodgkin Lymphoma: Recent Progress
FEATURING
Philippe Armand,
Alvaro Alencar
- 65 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on DLBCL: Finally Breaking the Back of R-CHOP?
FEATURING
Craig Moskowitz,
Alvaro Alencar
- 86 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on 1st Relapse in DLBCL: Induction Chemo & Autotransplant. Wait, Not So Fast…
FEATURING
Michael Bishop,
Phillip Scheinberg
- 13 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on Targeted Therapy in Indolent Lymphomas: The Role of PI3K & Other Inhibitors
FEATURING
Izidore Lossos,
Phillip Scheinberg
- 41 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on Waldenstrom’s Macroglobulinemia: The More Difficult Patient
FEATURING
Steven Treon,
Phillip Scheinberg
- 74 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 Discussion: What Are the Options in Primary CNS Lymphoma?
FEATURING
James Rubenstein,
Alvaro Alencar
- 37 views
- August 31, 2022